NAKANISHI INC.
Nakanishi Inc. engages in the manufacture and sale of dental, surgical, and general industrial products in Japan and internationally. The company offers dental equipment and chairs; air turbines; contra-angles; therapeutic motors; home visit medical equipment; oral hygiene products; endotherapy; oral surgery; maintenance and autoclave products; and technical products. It also provides general ind… Read more
NAKANISHI INC. (6SN) - Net Assets
Latest net assets as of : €- EUR
Based on the latest financial reports, NAKANISHI INC. (6SN) has net assets worth €- EUR as of .
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (€-) and total liabilities (€-). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | €- |
| % of Total Assets | 0% |
| Annual Growth Rate | N/A |
| 5-Year Change | N/A |
| 10-Year Change | N/A |
| Growth Volatility | N/A |
NAKANISHI INC. - Net Assets Trend (None–None)
This chart illustrates how NAKANISHI INC.'s net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for NAKANISHI INC. (None–None)
The table below shows the annual net assets of NAKANISHI INC. from None to None.
| Year | Net Assets | Change |
|---|---|---|
| No yearly data available. | ||
Equity Component Analysis
This analysis shows how different components contribute to NAKANISHI INC.'s total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- No equity composition insights available.
NAKANISHI INC. Competitors by Market Cap
The table below lists competitors of NAKANISHI INC. ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Shandong Weifang Rainbow Chemical Co. Ltd
SHE:301035
|
$847.99 Million |
|
Cham Swiss Properties AG
F:4U3
|
$848.13 Million |
|
Ambea AB
ST:AMBEA
|
$848.23 Million |
|
RPTCP
PINK:RPTCP
|
$848.25 Million |
|
Sun Hung Kai & Company Lt
PINK:SHGKY
|
$847.26 Million |
|
SF Diamond
SHE:300179
|
$847.06 Million |
|
Richinfo Technology Co Ltd Class A
SHE:300634
|
$847.03 Million |
|
United Energy Group Limited
PINK:UNEGF
|
$846.97 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in NAKANISHI INC.'s equity between the two most recent reporting periods.
Insufficient data available to analyze equity growth attribution.
Book Value vs Market Value Analysis
This analysis compares NAKANISHI INC.'s book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Insufficient data available to analyze book value vs market value.
Capital Efficiency Dashboard
This dashboard shows how efficiently NAKANISHI INC. utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Insufficient data available to analyze capital efficiency metrics.
Industry Comparison
This section compares NAKANISHI INC.'s net assets metrics with peer companies in the Medical Instruments & Supplies industry.
Industry Context
- Industry: Medical Instruments & Supplies
- Average net assets among peers: $9,394,036,854
- Average return on equity (ROE) among peers: 4.98%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| NAKANISHI INC. (6SN) | €- | N/A | N/A | $847.26 Million |
| Modern Dental Group Limited (1MD) | $2.36 Billion | 15.30% | 0.55x | $193.75 Million |
| SCHOTT Pharma AG & Co. KGaA (1SXP) | $709.04 Million | 17.68% | 0.69x | $482.88 Million |
| Alcon Inc. (2U3) | $19.26 Billion | 1.95% | 0.45x | $33.73 Billion |
| Shofu Inc. (69W) | $35.51 Billion | 8.83% | 0.23x | $215.32 Million |
| 7VG (7VG) | $176.36 Million | 14.92% | 1.12x | $684.88 Million |
| Bio-gate AG (BIG1) | $4.25 Million | -42.46% | 0.46x | $2.79 Million |
| Paul Hartmann AG (PHH2) | $690.37 Million | 10.65% | 0.81x | $776.29 Million |
| Sartorius AG VZO O.N. (SRT) | $497.08 Million | 9.76% | 1.56x | $6.78 Billion |
| Shandong Weigao Group Medical Polymer Company Limited (UK2) | $25.34 Billion | 8.16% | 0.37x | $1.36 Billion |